診斷實驗室自動化/監控解決方案的成長機會

Diagnostics Lab Automation and Monitoring Solutions Growth Opportunities

出版日期: 2024年06月17日 | 出版商:

Frost & Sullivan | 英文 60 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

自動化和數位資料交換的交叉為診斷實驗室釋放了價值

病理學勞動力短缺、準確性問題以及價格和資源分配不均是診斷行業持續面臨的挑戰。

實驗室檢測結果是您未來健康的基礎，影響 70% 的臨床決策。人口老化、非傳染性疾病、早發性癌症、第2型糖尿病以及其他心臟代謝和神經退化性疾病等持續趨勢預計將導致每年的實驗室檢查數量迅速增加。

因此，數位技術的進步正在穩步擴大診斷實驗室工具的使用範圍，超越傳統的醫療環境。消費者各個數位接觸點的全通路體驗的激增、行動應用程式、線上聚合平台的興起以及自我護理趨勢（例如預防性篩檢）正在推動病理實驗室數位使用者數量與前一年同期比較。某些技術，例如次世代定序，正在塑造高階專業測試的範圍，包括腫瘤學、產前診斷和感染疾病診斷。

在這種背景下，對於希望拓展新市場的病理實驗室來說，制定可靠的擴大策略來推動成長，同時提高彈性和永續性至關重要。許多實驗室正在與體外診斷供應商合作，以擴大存取範圍、最佳化網路組織並恢復實驗室生產力。這些努力正在改善測試結果的交付，並創建一個在整個經濟週期中持續的更相關的測試選單。

此外，策略性地利用數位化和自動化可以幫助實驗室根據不斷變化的消費者期望進行調整和發展，包括提高便利性、可負擔性和更快的周轉時間至關重要。然而，對遺留設備和工作流程的逐步升級可能會影響數位轉型的成熟度。可以執行智慧操作的機器人自動化和主動實驗室監控也正在進入該領域。實驗室自動化/監測解決方案產業的複合年成長率預計為 9.1%，是診斷行業的關鍵曲折點。

Lab test results are the foundation of future human health, influencing 70% of clinical decisions. A surge in lab tests' yearly volume will result from persistent trends, including aging populations, growing non-communicable diseases, early-onset cancers, type 2 diabetes, and other cardiometabolic and neurodegenerative diseases.

In consequence, advancements in digital technology are steadily expanding the availability of lab diagnostic tools beyond traditional medical settings. The popularity of omnichannel experiences across various consumer digital touchpoints and the rise of mobile apps, online aggregator platforms, and self-care trends (for instance, preventive checks) are boosting the year-over-year (YoY) number of digital users of pathology labs. Certain technologies, such as next-generation sequencing, are shaping the high-end specialized test spectrum, including oncology, prenatal, and infectious disease diagnostics.

In this context, a robust business expansion strategy that drives growth while also improving resilience and sustainability is critical for pathology labs looking to expand their business to new markets. Many labs have partnered with in vitro diagnostics vendors to increase access, optimize network organization, and recover lab productivity. These efforts improve test results' delivery and generate better-oriented test menus that persist throughout economic cycles.

Furthermore, the strategic use of digitization and automation is vital for labs to pivot and grow with changing consumer expectations-improved convenience, affordable pricing, and quicker turnaround times. However, incremental upgrades to legacy equipment and workflows may affect digital transformation maturity. Robotic automation and proactive lab monitoring capable of performing intelligent operations are also entering the sector. With a projected 9.1% CAGR, the lab automation and monitoring solutions industry is a significant inflection point in the diagnostics industry.

Strategic Imperatives

Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Lab Automation and Monitoring Solutions Industry
Growth Opportunities Fuel the Growth Pipeline Engine™